Vibalogics Revenue and Competitors

27472 Cuxhaven, Germany

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vibalogics's estimated annual revenue is currently $18.6M per year.(i)
  • Vibalogics's estimated revenue per employee is $155,000

Employee Data

  • Vibalogics has 120 Employees.(i)
  • Vibalogics grew their employee count by -17% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.8M19943%N/AN/A
#2
$33.7M174-10%$521.9MN/A
#3
$38.6M24916%N/AN/A
#4
$162.7M121933%N/AN/A
#5
$37.2M24028%N/AN/A
#6
$1.1M7N/AN/AN/A
#7
$19.7M12722%N/AN/A
#8
$18.3M118-3%N/AN/A
#9
$21.2M13712%$347.1MN/A
#10
$18.3M1187%$197.4MN/A
Add Company

Vibalogics offers process development, cGMP manufacturing and fill/finish of products based on viruses for companies involved in the development of vaccines, gene and oncolytic viral therapies in the biopharmaceutical industry. Services include: • Feasibility assessment • Technology transfer • Process development • cGMP manufacturing • Formulation/blending • Fill/finish (including liquid and lyophilized formulations) • QC analysis • Product release The primary goal of the company is to offer a full range of development and manufacturing services to its customers, underpinned by excellent quality and a transparent customer experience. The drugs that Vibalogics develop and manufacture on behalf of its customers are predominantly destined for use in clinical trials with the final aim of commercialising new products for prophylactic or therapeutic vaccination and treatment of life-threatening diseases.

keywords:N/A

N/A

Total Funding

120

Number of Employees

$18.6M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vibalogics News

2022-04-13 - VectorBuilder to spend $500M to construct gene therapy ...

Arranta specializes in microbiome therapeutic products and mRNA clinical production, while Vibalogics focuses on the production of oncolytic viruses, viral...

2022-03-22 - Vibalogics Completes Milestone In $50M Cuxhaven Facility ...

Vibalogics, a virotherapy contract development and manufacturing organization (CDMO) focused on the production of live viruses and viral...

2022-03-22 - Vibalogics adds capacity for virotherapy manufacturing in ...

Vibalogics, which was recently acquired by Swedish company, Recipharm, says the completion of its expansion project at its facility in...

2019-05-30 - Ampersand Acquires Vibalogics

Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector. Ampersand’s growth investment will ...

Vibalogics Executives


NameTitle
Mike DiMeoChief Financial Officer
Tom HochuliChief Executive Officer
Roger LiasChief Commercial Officer
Michael DiMeoChief Financial Officer
Kai LipinskiCSO
Hao QianVP, Process Sciences
Rodrigo MesquitaVP - Head of Operations
Matthew CoddVice President of Global Sales
Nick MasielloVice President Process Sciences
Joe SinclairVice President, Business Development and Corporate Strategy
Judith McCorryVice President Of Quality
Stefan BeyerPresident & Managing Director
Matt CoddVice President of Global Sales
Judith McCorryVice President Of Quality